Shao et al (17) suggested that the inhibition of NFκB activity is a plausible mechanism for apoptosis induced by the wild-type p53 gene transfer in human colon cancer cells and that anti-NFκB reagent aspirin may render these cells more susceptible to apoptosis. The gene discussed is TP53; the disease is colonic neoplasm.